Sung Lee
Förmögenhet: 5 M $ per 2026-08-31
Förmögenhet: 5 M $ per 2026-08-31
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer at MorphoSys AG from 2021 to 2023, and Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-01 | 63 221 ( 0,05 % ) | 4 M $ | 2026-08-31 | |
TANGO THERAPEUTICS, INC. 0,02 % | 2026-06-05 | 22 870 ( 0,02 % ) | 522 351 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Finansdirektör/CFO | 2024-05-08 |
| TANGO THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-01-05 |
| Företag | Position | Slut |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Finansdirektör/CFO | 2024-05-03 |
| MORPHOSYS AG | Finansdirektör/CFO | 2023-03-17 |
| SANGAMO THERAPEUTICS, INC. | Finansdirektör/CFO | 2021-02-01 |
| GILEAD SCIENCES, INC. | Investor Relations Kontakt | 2019-10-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån